Join
Loncar Cancer Immunotherapy ETF logo

CNCR

NASDAQ

Loncar Cancer Immunotherapy ETF

Sectorn/aIndustryn/aIPOn/a
$9.16+0.21 (+2.35%)
Follow
News0/Ratings0

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. Normally it will invest at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

Latest news

0 items

No recent news.

CNCR FAQ

6 questions
  • What does Loncar Cancer Immunotherapy ETF do?
    The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. Normally it will invest at least 80% of its total assets in the...
  • Where does CNCR stock trade?
    Loncar Cancer Immunotherapy ETF (CNCR) is listed on NASDAQ.
  • What sector and industry is CNCR in?
    Loncar Cancer Immunotherapy ETF operates in the n/a sector.
  • When did Loncar Cancer Immunotherapy ETF go public?
    Loncar Cancer Immunotherapy ETF (CNCR) completed its IPO in n/a.
  • What companies are similar to CNCR?
    Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare CNCR side-by-side with any of them on Quantisnow.
  • How can I track CNCR on Quantisnow?
    Quantisnow aggregates Loncar Cancer Immunotherapy ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CNCR to receive live email and push alerts on every new disclosure.